-
Over 11 million Chinese people benefit from major disease insurance
2024-04-07
Around 11.56 million urban and rural residents in China benefited from the country's major disease insurance in 2023, which eased the burden on individuals by 7,924 yuan (about 1,117 US dollars) on average, according to the National Healthcare Security Administration.
-
China provides medical assistance to 250m people in 2023
2024-04-07
China's healthcare security system provided medical assistance to 250 million patients in 2023, according to the country's National Healthcare Security Administration.
-
Innovative TCM Qinwei Granules approved for marketing
2024-03-23
The Category 1.1 innovative traditional Chinese medicine (TCM) Qinwei Granules of Chengdu Huaxi Natural Medicine Co Ltd was recently approved for marketing by the National Medical Products Administration.
-
Numbers report China's progress in medical and healthcare sector
2024-03-05
China's medical and healthcare sector witnessed sound progress last year, with the major health indicators reaching the forefront among middle- and high-income countries, according to data released by the National Health Commission.
-
Innovative TCM Jiuwei cough syrup approved for marketing
2024-02-27
Recently, the Category 1.1 innovative traditional Chinese medicine (TCM) Jiuwei Zhike Koufuye (cough syrup) of Zhuohe Pharmaceutical Group Co Ltd was approved for marketing by China's National Medical Products Administration.
-
Promulgation of the Rules for the Application of Discretion in Imposing Administrative Penalties in the Supervision and Administration of Medicinal Products
2024-02-23
Recently, the Rules for the Application of Discretion in Imposing Administrative Penalties in the Supervision and Administration of Medicinal Products were issued by China NMPA, which will come into force from August 1, 2024 onwards.
